Subscribe To
Baudax Bio Announces 1-for-40 Reverse Stock Split
MALVERN, Pa., Nov. 30, 2022 (GLOBE NEWSWIRE) — Baudax Bio, Inc. (NASDAQ:BXRX) a pharmaceutical company focused on innovative products for hospital and related settings, today announced that the Company’s Board of Directors has approved a 1-for-40 reverse stock split of its common shares (the “Reverse Stock Split”). The Reverse Stock Split will become effective at […] The post Baudax Bio Announces 1-for-40 Reverse Stock Split appeared first on ForexTV...
Read More
Posted: Nov 30 2022, 21:50
Author Name: forextv
Views: 111532